PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of agpsychBioMed Centralbiomed central web sitesearchsubmit a manuscriptregisterthis articleAnnals of General Psychiatry
 
Ann Gen Psychiatry. 2010; 9(Suppl 1): S157.
Published online 2010 April 22. doi:  10.1186/1744-859X-9-S1-S157
PMCID: PMC2991844

Cumulative effects of risperidone long acting injection and narrative therapy in treating ethanol dependency

Background

Aims/objectives: Rationale: Ethanol dependency is among the most frequent psychiatric disorders regardless of age and sex and currently affecting an increasing number of women and children. Its treatment stands on the clinician's decision, family and/or social group support. Our aim is to assess the efficacy of using risperidone long-acting injection along with psychotherapy in gamma type alcohol dependency.

Materials and methods

Method: Case study. Gathering self-reported data, psychotherapy sessions for the patient and his/her family, data analysis.

For relevance purposes we shall present below the case of a 30 yo Caucasian male with a history of alcohol consumption since he was 12 yo. During the past year his alcohol consumption started to follow a daily pattern. The patient's psychopathological presentation is dominated by psychomotor agitation, hypnic disorders, hetero-aggression, interpretative thoughts, depressive ideation, low self-esteem, social, professional and family desinsertion. Following the first four hospital admissions during which he received thymoregulatory, antidepressive and sedative agents his alcohol consumption increased and symptomatology intensified. During his fifth hospital admission the patient received risperidone 2 mg per day, as a neuroleptic agent, followed by risperidone long-acting injection 25 mg once every 2 weeks. After hospital discharge his condition improved incrementally. Two months after hospital release he relapses for two days but is able to cease consumption without external help. The patient is currently professionally and socially active and his family interactions are healthy. Along with risperidone long-acting injection therapy he was admitted to family therapy sessions every week during the first two months, every two weeks for the next two months followed by a monthly session during the next 6 months.

Conclusions

Using risperidone long-acting injections along with narrative therapy has protracted the abstinence period and has also contributed to social and family reinsertion.

References

  • White Michael. Maps of Narrative practice. Norton Professional Books. 2007.
  • Morgan Alice. What is Narrative Therapy, Gecko. 2002.

Articles from Annals of General Psychiatry are provided here courtesy of BioMed Central